References
- Bajgar J. 2004. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 38:151–216.
- Cabal J, Bajgar J. 1999. Tabun – reappearance 50 years later (in Czech). Chem Listy 93, 27–31.
- Cabal J, Kuca K, Kassa J. 2004. Specification of the structure of oximes able to reactivate tabun-inhibited acetylcholinesterase. Basic Clin Pharmacol Toxicol 95:81–86.
- Clement JG, Hansen AS, Boulet CA. 1992. Efficacy of HLö-7 and pyrimidoxime as antidotes of nerve agent poisoning in mice. Arch Toxicol 66:216–219.
- Ekström F, Akfur C, Tunemalm AK, Lundberg S. 2006. Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase. Biochemistry 45:74–81.
- Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95.
- Jokanovic M, Prostran M. 2009. Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds. Curr Med Chem 16:2177–2188.
- Kassa J, Cabal J. 1999a. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods. Toxicology 132:111–118.
- Kassa J, Cabal J. 1999b. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with presently used oximes and H oximes against sarin by in vitro and in vivo methods. Hum Exp Toxicol 18:560–565.
- Kassa J, Cabal J. 1999c. A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexyl methylphosphonofluoridate (GF agent) by in vitro and in vivo methods. Pharmacol Toxicol 84:41–45.
- Kassa J, Karasova J, Musilek K, Kuca K. 2008. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Toxicology 243:311–316.
- Kassa J. 2002. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 40:803–816.
- Kovarik Z, Vrdoljak AL, Berend S, Katalinic M, Kuca K, Musilek K, Radic B. 2009. Evaluation of oxime k203 as antidote in tabun poisoning. Arh Hig Rada Toksikol 60:19–26.
- Kuca K, Cabal J, Kassa J. 2004. A comparison of the efficacy of a bispyridinium oxime–1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods. Pharmazie 59:795–798.
- Kuca K, Juna D, Musilek K. 2006. Structural requirements of acetylcholinesterase reactivators. Mini Rev Med Chem 6:269–277.
- Lotti M. 2000. Organophosphorus compounds. In: Spencer PS, Schaumburg HH, eds. Experimental and Clinical Neurotoxicology. New York, NY, USA: Oxford University Press, 898–925.
- Lundy PM, Hamilton MG, Sawyer TW, Mikler J. 2011. Comparative protective effects of HI-6 and MMB-4 against organophosphorous nerve agent poisoning. Toxicology 285:90–96.
- Marrs TC, Rice P, Vale JA. 2006. The role of oximes in the treatment of nerve agent poisoning in civilian casualties. Toxicol Rev 25:297–323.
- Mercey G, Verdelet T, Renou J, Kliachyna M, Baati R, Nachon F, Jean L, Renard PY. 2012. Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents. Acc Chem Res 45:756–766.
- Musilek K, Jun D, Cabal J, Kassa J, Gunn-Moore F, Kuca K. 2007. Design of a potent reactivator of tabun-inhibited acetylcholinesterase–synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203). J Med Chem 50:5514–5518.
- Musilek K, Komloova M, Holas O, Horova A, Pohanka M, Gunn-Moore F, Dohnal V, Dolezal M, Kuca K. 2011. Mono-oxime bisquaternary acetylcholinesterase reactivators with prop-1,3-diyl linkage-Preparation, in vitro screening and molecular docking. Bioorg Med Chem 19:754–762.
- Tallarida R, Murray R. 1987. Manual of pharmacological calculation with computer programs. New York, NY, USA: Springer-Verlag.
- Worek F, Widmann R, Knopff O, Szinicz L. 1998. Reactivating potency of obidoxime, pralidoxime, HI 6 and HLö 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch Toxicol 72:237–243.
- Worek F, Wille T, Koller M, Thiermann H. 2012. Reactivation kinetics of a series of related bispyridinium oximes with organophosphate-inhibited human acetylcholinesterase–Structure-activity relationships. Biochem Pharmacol 83:1700–1706.